Table 3.
Characteristics of 14 Index-partner Pairs with HIV-1 Infections and an HIV-1 pol Sequence Available
| Pair ID | Participant | Gender | Age | Married | HIV-1 RNA (Copies/mL) |
Days to First Seqa | Genetic Distanceb | Major Drug Resistance Mutation |
|---|---|---|---|---|---|---|---|---|
| 1 | Index | M | 41 | 0 | >10 000 000 | 7 | 0.004 | … |
| 1 | Partner | F | 27 | 1 | 281 895 | 15 | … | |
| 2 | Index | F | 35 | 0 | >10 000 000 | 7 | 0.003 | … |
| 2 | Partner | M | 32 | 1 | 201 030 | 91 | … | |
| 3 | Index | F | 19 | 1 | 2 538 529 | 5 | 0.003 | … |
| 3 | Partner | M | 25 | 1 | 298 907 | 14 | … | |
| 4 | Index | F | 23 | 1 | 14 975 | 12 | 0.007 | … |
| 4 | Partner | M | 27 | 1 | 94 271 | 12 | … | |
| 5 | Index | F | 38 | 1 | 168 106 | 12 | 0.001 | … |
| 5 | Partner | M | 49 | 1 | >10 000 000 | 17 | … | |
| 6 | Index | M | 27 | 1 | >10 000 000 | 4 | 0.004 | … |
| 6 | Partner | F | 20 | 1 | 20 076 | 7 | … | |
| 7 | Index | M | 23 | 1 | 2 141 468 | 7 | 0.005 | … |
| 7 | Partner | F | 27 | 1 | 192 750 | 17 | … | |
| 8 | Index | F | 25 | 0 | >10 000 000 | 10 | 0.007 | M184V, T215F, K103N |
| 8 | Partner | NA | NA | NA | 131 763 | 25 | M184V, T215F, K103N | |
| 9 | Index | F | 19 | 1 | 1 485 143 | 10 | 0.012 | … |
| 9 | Partner | M | 21 | 1 | 2982 | 18 | V106VAMT,Y181YC | |
| 10 | Index | M | 30 | 1 | 951 731 | 6 | 0.011 | … |
| 10 | Partner | F | 36 | 1 | 12 296 | 17 | … | |
| 11 | Index | M | 23 | 1 | 208 792 | 8 | 0.004 | … |
| 11 | Partner | F | 34 | 0 | NA | 11 | … | |
| 12 | Index | F | 25 | 1 | 109 739 | 5 | 0.001 | K103N |
| 12 | Partner | M | 34 | 1 | 110 615 | 11 | … | |
| 13 | Index | M | 29 | 1 | 3 517 217 | 15 | 0.003 | K103N |
| 13 | Partner | F | 21 | 1 | 389 | 34 | K103N | |
| 14 | Index | F | 21 | 1 | 491 952 | 6 | 0.042 | … |
| 14 | Partner | M | 21 | 1 | 108 970 | 9 | … |
Abbreviations: HIV, human immunodeficiency virus; NA, not available.
aDays from diagnosis (index cases) or enrollment (partners) to HIV-1 sequences sampling.
bPairwise genetic distance between HIV-1 partial pol sequences (substitutions per site), calculated using the general time-reversible model of nucleotide substitution.